Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

Ameen Abdulla Salahudeen, Manali I. Patel, Paul Baas, Walter J. Curran, Jeffrey D. Bradley, David R Gandara, Glenwood D. Goss, Tony S. Mok, Suresh S. Ramalingam, Everett E. Vokes, Shakun M. Malik, Heather A. Wakelee

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Survival rates of patients with either early and advanced stage non-small-cell lung cancer (NSCLC) have improved with newer systemic therapy and radiation techniques, including combination regimens, targeted therapies, and immunotherapies. The cancer cooperative groups have historically played a critical role in the advancement of NSCLC therapy. Annually, representatives from cooperative groups worldwide convene at the International Lung Cancer Congress (ILCC). In summer 2015, the ILCC reached its 16th anniversary. This article highlights the NSCLC studies presented by participating groups in 2015.

Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Feb 25 2016

    Fingerprint

Keywords

  • Cooperative group
  • Mesothelioma
  • NCTN
  • NSCLC
  • SCLC

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Salahudeen, A. A., Patel, M. I., Baas, P., Curran, W. J., Bradley, J. D., Gandara, D. R., Goss, G. D., Mok, T. S., Ramalingam, S. S., Vokes, E. E., Malik, S. M., & Wakelee, H. A. (Accepted/In press). Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2016.06.007